It is a pharma public limited company based in Chennai, Tamil Nadu, India, established in 2008.
2008 | Chennai, Tamil Nadu, India | ActiveNexzen Formulations Limited, a active public limited company, was established on 11 June 2008 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230TN2008PLC068133. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
Formerly known as Nexzen Formulations Private Limited. It upholds a compliant status. Employing 17 professional, Its leadership includes Venkatasatyananda Koteswara Rao Boggarapu (Director), Malini Cheedella (Director), Kirankumar Venkata Sathyasai Boggarapu (Director). It holds ₹4.90 M open charges and no settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at 67/2, 3Rd Street, Railway Colony Nmm Road,, Chennai, Tamil Nadu, 600029.
U24230TN2008PLC068133
068133
11 June 2008
₹1.00 Cr
₹1.00 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Nexzen Formulations Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkatasatyananda Koteswara Rao Boggarapu | Director | 09 Mar 2009 | Current |
| Malini Cheedella | Director | 11 Jun 2008 | Current |
| Kirankumar Venkata Sathyasai Boggarapu | Director | 11 Jun 2008 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nexzen Formulations Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.01% increase. The company also saw a substantial improvement in profitability, with a 26.24% increase in profit. The company's net worth moved up by a moderate rise of 0.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Nexzen Formulations had a promoter holding of 37.19% and a public holding of 62.81%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,900,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jan 2015 | Andhra Bank | ₹4.90 M | Open |
Explore comprehensive loan charge details -
Nexzen Formulations has a workforce of 17 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nexzen Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexzen Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nexzen Formulations Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was documented.
Nexzen Formulations Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was recorded as a recent event.
Progress on A charge with Andhra Bank amounted to Rs. 0.49 Cr with Charge ID 10551539 was registered on 03 Jan 2015. was documented.
Progress on Venkatasatyananda Koteswara Rao Boggarapu was appointed as a Director was appointed as a Director on 09 Mar 2009 & has been associated with this company since 16 years 9 months . was documented.
Progress on Malini Cheedella was appointed as a Director was appointed as a Director on 11 Jun 2008 & has been associated with this company since 17 years 6 months . was documented.
Kirankumar Venkata Sathyasai Boggarapu was appointed as a Director was appointed as a Director on 11 Jun 2008 & has been associated with this company since 17 years 6 months . was recorded as a recent event.
The CIN of Nexzen Formulations Limited is U24230TN2008PLC068133.
Nexzen Formulations Limited is headquartered at 67/2, 3Rd Street, Railway Colony Nmm Road,, Chennai, Tamil Nadu, 600029.
Nexzen Formulations Limited was incorporated on 11 June 2008.
The current directors of Nexzen Formulations Limited are
The primary industry of Nexzen Formulations Limited is Trade.
Nexzen Formulations Limited is unlisted.
The authorized capital of Nexzen Formulations Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Nexzen Formulations Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX